Optimal biomedical products from unique technology

CureNology creates innovative biomedical products that meet the needs of the field based on the scarcity of technology.

Core Competitiveness

Scarcity of Technology

The safest and most effective regenerative treatment technology

World’s first regenerative treatment technology - both mass-producible and personalized applications are capable.

Growth Potential

Applicable for both Aesthetic & Medical regenerative treatment

• New cosmeceutical lines growth market share

• Applicable to various organ/disease type

• Potential for one and only medical solutions in Gum Recess treatment and Spinal cord injury regeneration

• Continuously expand new applications in ECM-related tissue regeneration

Profitability

Cash cow cosmeceutical product generates stable and growing revenue

Expected series of launching highly profitable medical device product pipelines in 2025 through 2028.

Stability

Securing cosmeceutical sales country exclusive distribution and E-commerce

Solid technological foundation for continuous R&D and new product launching in both cosmeceutical and medical devices.

Key persons

Dr. J

CTO, Founder

Worked at
Pfizer

Studied in
Boston University
Columbia University
Washington University

M.K. Seon

CEO, Co-founder

Worked at
H.N. Oriental Medicine Clinic
Daewoo Foundation
DASAN Networks
Daewoo Motors

Paul Cho

GM

Worked at
KAIENTEC
LANXESS
Bayer

Studied in
INHA University, Korea

Hassan El Amri

CMO

Worked at
Saltigo
BASF

Studied in
Humboldt-Universität zu Berlin

Learn more about
CureNology Philosophy

Learn more about
CureNology Technology

Be our partner
Contact us